Home » Topics » BioWorld Science

BioWorld Science
RSS

Ionis initiates phase III study of ION-363

April 6, 2021

New nitazoxanide derivatives synthesized at Beijing Junke Huayuan Med Tech

April 6, 2021

Seven mostly unknown genes bring order to minimal genome cell division

April 6, 2021

BenevolentAI Bio patents tyrosine-protein kinase ABL1 inhibitors

April 6, 2021

New IRAK-4 inhibitors discovered at Shanghai Institute of Materia Medica

April 6, 2021

Roche identifies new MAGL inhibitors

April 6, 2021

Biotheus describes antibodies targeting carbonic anhydrase IX

April 6, 2021

Positive phase I/II data for VLA-2001 COVID-19 vaccine candidate

April 6, 2021

Initial clinical data from phase I/II SWORD-1 study of TPX-0046

April 6, 2021

DMC approves increased dosing frequency in phase II study of Brilacidin for COVID-19

April 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...